This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
5 Life Insurers to Watch Amid a Still-Low Rate Environment
by Tanuka De
Redesigning and repricing of products and services, as well as increased automation, will help life insurers like SLF, LNC, VOYA, PRI and AEL sail through a persistent low-rate environment.
MFC or SLF: Which Stock is Better-Placed at the Moment?
by Zacks Equity Research
Manulife (MFC) and Sun Life (SLF) are poised to grow in the promising life insurance space. We try to find out which one fares better via comparative evaluation.
Here's Why Hold is an Apt Strategy for Sun Life (SLF) Stock
by Zacks Equity Research
Sun Life (SLF) is shifting its growth focus toward products that park lower capital and offer more predictable earnings to improve the business mix.
Why Should You Retain Manulife (MFC) in Your Portfolio?
by Zacks Equity Research
Manulife (MFC) is poised to grow, given its solid in-force business growth, disciplined expense management, and expanding wealth and asset management business.
Reasons Why Brighthouse (BHF) Stock is an Attractive Pick Now
by Zacks Equity Research
Brighthouse (BHF) is well poised for growth on the back of conservative investment strategy, sufficient liquidity and prudent capital deployment.
What Makes Sun Life (SLF) a New Buy Stock
by Zacks Equity Research
Sun Life (SLF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sun Life Financial (SLF) to Divest Sponsored Markets Business
by Zacks Equity Research
Sun Life's (SLF) pending divestiture of sponsored markets business to Canadian Premier is likely to help the company intensify its focus on growing the core segments within the group benefits business.
Why Is Sun Life (SLF) Down 6.1% Since Last Earnings Report?
by Zacks Equity Research
Sun Life (SLF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Down 5.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Sun Life (SLF)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Sun Life (SLF) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Sun Life Financial (SLF) Gains 25% YTD: More Room for Upside?
by Zacks Equity Research
Focus on Asia operation, growing asset management businesses and strong financial position continue to drive Sun Life
Why Should You Hold Manulife (MFC) Stock in Your Portfolio?
by Zacks Equity Research
Growing Asia business, expanding Wealth and Asset Management business, cost savings to improve profitability and solid capital position poise Manulife (MFC) to grow.
Sun Life Financial (SLF) Q3 Earnings Increase Year Over Year
by Zacks Equity Research
Sun Life (SLF) Q3 results reflect business growth, higher large case sales in Group Benefits, mutual fund sales in India and favorable credit experience.
Lincoln National (LNC) Q3 Earnings Miss Estimates, Up Y/Y
by Zacks Equity Research
Lincoln National's (LNC) third-quarter earnings miss estimates but improve significantly year over year driven by solid segmental contributions and lower expenses.
Amazon's (AMZN) AWS Gets Selected by NXP Semiconductors
by Zacks Equity Research
Amazon's (AMZN) AWS gets chosen by NXP Semiconductors as its preferred cloud provider.
Why Sun Life (SLF) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Sun Life (SLF) have what it takes? Let's find out.
MetLife (MET) Ups Stake in PNB Metlife to Boost India Presence
by Zacks Equity Research
MetLife (MET) inks deal to purchase combined stake of IGE and Elpro in PNB MetLife. With increased stake in India's JV, the company intends to bolster its presence in India.
Sun Life (SLF) to Expand Dental Business With DentaQuest Buyout
by Zacks Equity Research
Sun Life Financial (SLF) has agreed to buy DentaQuest to boost its capabilities in the U.S. dental benefits space.
Here's Why You Should Retain Sun Life Financial (SLF) Stock
by Zacks Equity Research
Sun Life Financial (SLF) is well-poised to benefit from higher wealth sales, favorable credit experience and sturdy financial position.
Covenant Logistics, Nike, Amazon, Sun Life and Microsoft highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Covenant Logistics, Nike, Amazon, Sun Life and Microsoft highlighted as Zacks Bull and Bear of the Day
Amazon (AMZN) Boosts Cloud Portfolio With New Capabilities
by Zacks Equity Research
Amazon's (AMZN) AWS unveils the latest capabilities for Amazon Connect namely, Amazon Connect Wisdom, Amazon Connect Voice ID and high-volume outbound communications.
Why Is Sun Life (SLF) Down 0.1% Since Last Earnings Report?
by Zacks Equity Research
Sun Life (SLF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Amazon's (AMZN) AWS Clientele Expands With Sun Life's Selection
by Zacks Equity Research
Amazon's (AMZN) AWS gets chosen by Sun Life as its long-term strategic cloud technology provider.
Sun Life (SLF) Stock Up 17% YTD: Can it Retain the Momentum?
by Zacks Equity Research
Focus on Asia operation, growing asset management businesses and sturdy financial position continue to drive Sun Life (SLF).
Sun Life Financial (SLF) Q2 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Sun Life's (SLF) Q2 results reflect business growth and favorable credit experience, partially offset by unfavorable impacts of foreign exchange translation, lower investing activity and unfavorable expense experience.
Lincoln National (LNC) Q2 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Lincoln National's (LNC) second-quarter results highlight revenue growth, solid segmental performances and reduced mortality impact, partly offset by escalating costs.